Kirsten Flowers

Chief Commercial Officer, Kura Oncology.

Companies

PMV Pharmaceuticals, Inc.Board member Jan 10, 2022 to now¹
Comera Life Sciences Holdings, Inc.Board member May 20, 2022 to Nov 14, 2023²
Kura OncologyChief Commercial Officer Jan 7, 2020 to Jan 31, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Kura Oncology KURA20,605 shares⁴$189.8K at $9.21Jan 27, 2023
Comera Life Sciences Holdings, Inc.22,199 shares⁵Jan 4, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 27, 2023Sold 1,906 shares at $13.89 of Kura Oncology⁴
Jan 4, 2023Bought 13,513 shares at $1.23 of Comera Life Sciences Holdings, Inc.⁵
Jan 4, 2023Granted 13,513 shares at $1.23 of Comera Life Sciences Holdings, Inc.⁶
Jan 26, 2022Granted 21,900 shares of Kura Oncology⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPMV Pharmaceuticals, Inc., Board member
2
SEC EDGARComera Life Sciences Holdings, Inc., Board member
3
SEC EDGARKura Oncology, Chief Commercial Officer
4
SEC EDGARKura Oncology shares after the filing of Jan 27, 2023
5
SEC EDGARComera Life Sciences Holdings, Inc. shares after the filing of Jan 4, 2023
6
SEC EDGARForm 4 filed Jan 6, 2023
7
SEC EDGARForm 4 filed Jan 28, 2022